Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The Alanine Serine Cysteine Transporter 2 (ASCT2) is involved in balancing the intracellular amino acid pool. This function is allowed by the antiport mechanism and the asymmetric specificity towards different neutral amino acids, distinctive of this transporter. In the present work, the interaction of the putative substrate Cys with the human ASCT2 has been studied using the recombinant hASCT2 over‐produced in Pichia pastoris and the native ASCT2 extracted from HeLa in both proteoliposomes and intact cells. It was found that Cys is a potent competitive inhibitor of hASCT2 but is not a substrate. Moreover, Cys binding to a second site, different from that of substrate, triggers a protein‐mediated unidirectional Gln efflux.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrient-sensing mechanisms and pathways
Efeyan, A., Comb, W. C., & Sabatini, D. M. (2015) · Nature · doi:10.1038/nature14190 · Cited by 1,110 · cited 1×
“Indeed, the capacity to catalyze bidirectional transport of Gln, Ser, Asn, Thr but only inward transport of Ala, Val, Met reflects the physiological role of hASCT2 in correcting imbalances of intracellular amino acid pools [5] revealed by molecular sensors [10,11].”
BackgroundSLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673 · cited 1×
“Indeed, the capacity to catalyze bidirectional transport of Gln, Ser, Asn, Thr but only inward transport of Ala, Val, Met reflects the physiological role of hASCT2 in correcting imbalances of intracellular amino acid pools [5] revealed by molecular sensors [10,11].”
BackgroundSelf-citationThe SLC1 high-affinity glutamate and neutral amino acid transporter family
Kanai, Y., Clémençon, B., Simonin, A., Leuenberger, M., Lochner, M., Weisstanner, M., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.001 · Cited by 329
Cited by
Cysteine Metabolism in Neuronal Redox Homeostasis
Paul, B. D., Sbodio, J. I., & Snyder, S. H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.007 · Cited by 356
“ASCT2 is not considered to be a major contributor to cysteine transport, but its activity can be modulated by cysteine [32, 33].”
BackgroundThe Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival
Combs, J. A., & DeNicola, G. M. (2019) · Cancers · doi:10.3390/cancers11050678 · Cited by 272
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
Scalise, M., Pochini, L., Console, L., Losso, M. A., & Indiveri, C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00096 · Cited by 265
Self-citationGlutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
Scalise, M., Pochini, L., Galluccio, M., Console, L., & Indiveri, C. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00306 · Cited by 183
“Recently, we showed that the actual preferred substrate is Glutamine and that Cysteine is not a substrate but, probably, a modulator of transport activity, in agreement with the previous reports describing a very low transport of Cysteine, if any (49, 50).”
ResultSelf-citationThe Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Metadata
- Authors
- Scalise, M., Pochini, L., Pingitore, P., Hedfalk, K., & Indiveri, C.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2015-10-19
- Volume
- 589
- Issue
- 23
- Pages
- 3617-3623
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2117460363
- Cited by
- 48
- References
- 3
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.